Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium. (Q33273354)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium. |
scientific article |
Statements
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium (English)
Birgit Geoerger
Didier Frappaz
Bruce Morland
Anna Ndiaye
Gabriel Kalifa
Fabienne Pichon
Sharon Hain
Francoise Boderet
Jacques Bosq
Jean-Francois Emile
Renaud Capdeville
Gilles Vassal
Innovative Therapies for Children with Cancer European Consortium